CLYM: Rega marang dodolan Climb Bio Inc.

Simbol lan logo merek Climb Bio, Inc. (CLYM)

Climb Bio Inc (CLYM) previously faced liquidity shortages due to R&D expenses, as confirmed by the price-to-sales ratio. The current value of reflects the metric's balance on the chart. The company relies on third-party contractors for molecule synthesis while developing a comprehensive therapy system for immune disorders to achieve patient remission.

CLYM climbbio.com: Rasio rega marang pendapatan ing interval 04.07.2022 - 13.11.2026

Rincian metrik lan analitis perusahaan Climb Bio, Inc. (CLYM)

- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
Analisis umum perusahaan:climbbio.com CLYM
Barang utama Climb Bio Inc

Investors are assessing the stability of Climb Bio Inc (CLYM) through the price-to-sales ratio, which determines the value of every dollar of the business's revenue. By analyzing the P/S multiple, one can correlate the current valuation with the potential for long-term margins driven by immunology patents and high demand inertia for continuous treatment.

Karo sapa Climb Bio Inc saingan

argenx.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (BioNTech)|Abivax Pharma (ABVX) - Rega marang dodolan|ADMA Bio - Multiplikator P/S|Protagonist Corp (PTGX) - Kapitalisasi marang pendapatan|Immunovant, Inc. (IMVT) - Rasio rega marang pendapatan|KNSA (kiniksa.com) - Rasio rega marang pendapatan|GRFS (Grifols) - Multiplikator P/S|Adaptive Biotech (ADPT) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Celldex (CLDX)|Kapitalisasi marang pendapatan Aurinia Corp AUPH|Multiplikator P/S BCRX (BioCryst)|veratx.com - Rasio rega marang pendapatan|DNTH: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan PHVS (Pharvaris NV)|ABCL: Multiplikator P/S|TRML (Tourmaline) - Rasio rega marang pendapatan|PGEN (Precigen, Inc.) - Multiplikator P/S|pharming.com (PHAR) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Nektar Therapeutics Inc. (NKTR)|UPB - Rega marang dodolan|Zenas Biopharma, Inc. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan IMNM|Gossamer Bio, Inc. - Multiplikator P/S|Koefisien rega marang pendapatan kalvista.com KALV|Septerna (SEPN) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan PVLA|SVRA (Savara Corp) - Multiplikator P/S|Kapitalisasi marang pendapatan Rigel Corp (RIGL)|Multiplikator P/S ANAB|Kapitalisasi marang pendapatan astriatx.com ATXS|Rasio rega marang pendapatan enGene ENGN|RAPT Therapeutics Inc. - Rasio rega marang pendapatan|JBIO: Kapitalisasi marang pendapatan|Rega marang dodolan Aclaris Therapeutics, Inc|Kyverna Therapeutics (KYTX) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan tizianalifesciences.com|Rasio rega marang pendapatan Cabaletta Bio|Ventyx Biosciences Inc. - Rasio rega marang dodolan|Multiplikator P/S THTX|AVTX (Avalo Therapeutics Inc) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ELDN (Eledon Pharmaceuticals)|Multiplikator P/S agenusbio.com AGEN|ZURA - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ATYR (aTyr Pharma Inc)|adagene.com (ADAG) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan Ikena Oncology|STTK (Shattuck Labs Inc) - Multiplikator P/S|Multiplikator P/S Equillium Bio|Kapitalisasi marang pendapatan CNTB (Connect Biopharma)|IMUX (immunic-therapeutics.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ATRA (Atara Bio)|Koefisien rega marang pendapatan InflaRx NV (IFRX)|XFOR - Rasio rega marang pendapatan|Adicet Bio (ACET) - Kapitalisasi marang pendapatan|celularity.com (CELU) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan INmune Bio Inc|Kapitalisasi marang pendapatan BRNS|Multiplikator P/S Kezar Life Sciences Inc|Rasio rega marang pendapatan SAB Biotherapeutics (SABS)|akaritx.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S ENLV (Enlivex Therapeutics Ltd.)|Q32 Bio Inc (QTTB) - Rega marang dodolan|GeoVax Labs Inc - Multiplikator P/S|Edesa Biotech Corp (EDSA) - Kapitalisasi marang pendapatan|iBio, Inc. (IBIO) - Rasio rega marang pendapatan|CARM (Carisma Therapeutics Inc.) - Rasio rega marang pendapatan|XTLB (XTL Biopharmaceuticals Ltd.) - Multiplikator P/S|Bolt Bio (BOLT) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan HCW Biologics Inc. (HCWB)|Kapitalisasi marang pendapatan aptevotherapeutics.com APVO|Multiplikator P/S AIM (AIM ImmunoTech Inc.)|Aditxt Inc. - Rasio rega marang pendapatan|GRI: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan XRTX (XORTX Therapeutics Inc)|HIND: Multiplikator P/S|REVB (Revelation Biosciences Corp) - Rasio rega marang pendapatan|INDP (Indaptus Therapeutics) - Multiplikator P/S|scinai.com (SCNI) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan CalciMedica, Inc. (CALI)|AFMD - Rega marang dodolan|Allakos - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan HOOK|IGM Bio - Multiplikator P/S|Koefisien rega marang pendapatan iteostherapeutics.com ITOS|Ocean Biomedical (OCEA) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan TCBP|THRD (Third Harmonic Bio, Inc) - Multiplikator P/S